You are viewing an incomplete version of our website. Please click to reload the website as full version.

Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, and Dihydroorotase (CAD) (C-Term) Peptide

Details for Product No. ABIN1381998, Supplier: Log in to see
Protein Name
  • 38E.19
  • CAD
  • CG1759
  • Cad
  • Dmel\\CG1759
  • S67
  • anon-WO2004063362.83
  • cd
  • Cpad
  • AU018859
  • 2410008J01Rik
  • cb456
  • wu:fc30c12
  • wu:fc33d01
  • wu:fc67g02
  • si:dkey-221h15.3
  • xcad
  • 40kDa
  • 5730477D02Rik
  • CPAN
  • DFF40
  • Didff
  • caudal
  • carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
  • DNA fragmentation factor, beta polypeptide (caspase-activated DNase)
  • DNA fragmentation factor, beta subunit
  • cad
  • Cad
  • CAD
  • dffb
  • Dffb
Protein Region
C-Term
Origin
Mouse (Murine)
3
2
1
1
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Pubmed
3 references available
Blocked Antibody anti-Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, and Dihydroorotase (CAD) (C-Term) antibody (ABIN1030307)
Characteristics 16 amino acids near the carboxy terminus of mouse CAD.
Mouse
Research Area Chromatin and Nuclear Signaling, Cell Cycle, Apoptosis/Necrosis
Application Notes CAD peptide is used for blocking the activity of CAD.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Enari, Sakahira, Yokoyama, Okawa, Iwamatsu, Nagata: "A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD." in: Nature, Vol. 391, Issue 6662, pp. 43-50, 1998 (PubMed).

Schneider, Thome, Burns, Bodmer, Hofmann, Kataoka, Holler, Tschopp: "TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB." in: Immunity, Vol. 7, Issue 6, pp. 831-6, 1998 (PubMed).

Pitti, Marsters, Ruppert, Donahue, Moore, Ashkenazi: "Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family." in: The Journal of biological chemistry, Vol. 271, Issue 22, pp. 12687-90, 1996 (PubMed).